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Abstract 
 
The molecular basis involving adsorption of pulmonary surfactant at the respiratory air-liquid 
interface (ALI) and the specific roles of the surfactant proteins SP-B and SP-C in this process have 
not been completely resolved. The reasons might be found in the largely unknown structural 
assembly in which surfactant lipids and proteins are released from alveolar type II cells, and the 
difficulties to sample, manipulate and visualize the adsorption of these micron-sized particles at an 
ALI under appropriate physiological conditions. Here, we introduce several approaches to overcome 
these problems. First, by immunofluorescence we could demonstrate the presence of SP-B and SP-C 
on the surface of exocytosed surfactant particles. Second, by sampling the released particles and 
probing their adsorptive capacity we could demonstrate a remarkably high rate of interfacial 
adsorption whose rate and extent was dramatically affected by treatment with antibodies against SP-
B and SP-C. The effect of both antibodies was additive and specific. Third, direct microscopy of an 
inverted ALI revealed that the blocking effect is due to a stabilization of the released particles when 
contacting the ALI, precluding their transformation and the formation of surface films. We conclude 
that SP-B and SP-C are acting as essential, preformed molecular keys in the initial stages of 
surfactant unpacking and surface film formation. We further propose that surfactant activation might 
be transduced by a conformational change of the surfactant proteins upon contact with surface forces 
acting on the ALI. 
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Introduction 
 
Pulmonary surfactant is a surface active lipoprotein complex synthesized by the alveolar type II (AT 
II) cells. It is stored in special organelles, the lamellar bodies (LBs), probably in the form of tightly 
packed lipid bilayers in small repeat distances (Ochs, 2010). Upon stimulation of AT II cells, this 
dense lipoprotein-complex is released into the thin alveolar lining fluid (Bastacky et al., 1995) by 
constitutive and regulated exocytosis (Dietl and Haller, 2005;Frick et al., 2001) and in an active 
squeeze-out process through a constricted fusion pore (Miklavc et al., 2012). After secretion, the 
surfactant complexes are essentially stable in the aqueous milieu even demonstrating considerable 
viscoelastic properties (Singer et al., 2003). They maintain this particulate, spherical structure (= 
lamellar body like particles, LBPs; (Ravasio et al., 2010)) until contact with a clean air-liquid 
interface (ALI), where LBPs (Ø 1-5 µm) spontaneously and rapidly disintegrate to deliver surface 
active materials into the expanding surface film (Ravasio et al., 2010;Hobi et al., 2014;Haller et al., 
2004;Bertocchi et al., 2005). Evidence is growing that LBPs constitute the most original form in 
which surfactant is exocytosed by the AT II cells, and tubular myelin is suggested as a secondary, 
but not obligatory, form feeding directly into a growing surface film (Perez-Gil, 2008). 
 
The major fraction of pulmonary surfactant is composed of lipids, predominantly saturated 
phospholipids like dipalmitoylphosphatodylcholine (DPPC) and a minor fraction of neutral lipids 
such as cholesterol. The specific phospholipid composition, in particular the high amount of DPPC, 
makes surfactant a biologically unique membrane system able to sustain high surface pressures and 
thus to maintain a very low surface tension (γ) upon lateral compression. However, the stiff nature of 
DPPC compromises the flexibility and the dynamics of the interfacial structures. These properties, 
which are of critical importance during the respiratory cycle, are assured by the hydrophobic 
surfactant proteins B and C (Perez-Gil, 2008). 
 
SP-B, a 79-residue polypeptide belonging to the saposin-like protein family (Parra et al., 2013) has a 
molecular weight of 8.7 kDa and preferably forms a covalent homodimer of 19 kDa, which is the 
most abundant protein configuration found in surfactant membranes (Hawgood et al., 1998;Perez-
Gil, 2008). Due to its high hydrophobicity SP-B is permanently membrane-associated and it 
primarily interacts with anionic phospholipids like phosphatidylglycerol (PG) (Cabre et al., 
2012;Perez-Gil et al., 1995). Its amphipathic character and the presence of charged residues suggest 
a superficial interaction of SP-B with both bilayers and monolayers. SP-B binds to phospholipid 
membranes, promotes membrane-membrane contacts (Cabre et al., 2009) causes lipid fusion, and 
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contributes to the formation of multilayer lipid structures (Bernardino et al., 2013). Interestingly, SP-
B has a strong tendency to form large oligomers in bi- and monolayers, probably forming large 
hydrophobic pores (Olmeda et al., 2015). Furthermore, SP-B also plays a critical role in the 
intracellular biogenesis of surfactant, being required for the proper formation of LBs and the 
proteolytic processing of SP-C (Stahlman et al., 2000). The absolutely decisive function and clinical 
relevance of SP-B is undoubted, since several studies describe that a complete lack of SP-B in 
newborn mice and humans cause lethal respiratory failure at birth (Clark et al., 1995;Melton et al., 
2003;Tokieda et al., 1997;Weaver and Beck, 1999). SP-C, a small lipopeptide of 4.5 kDa with 35 
residues, is exclusively produced in lungs by the AT II cells. Its amino acid sequence includes in 
most species two neighboring cysteines which are palmitoylated. This post-translational modification 
confers a tight association of the protein N-terminal segment with bilayers and interfacial films, 
thereby preventing its exclusion from the interface during compression (Lukovic et al., 
2012;Plasencia et al., 2001). Thus, SP-C is believed to promote and stabilize membrane-interface 
contacts and to facilitate lipid exchange between lipid layers (Glasser et al., 2001;Lukovic et al., 
2012). In contrast to SP-B, SP-C is not as absolutely essential for lung ventilation and survival. 
However, SP-C deficient mice ultimately develop chronic respiratory failure (Glasser et al., 
2008;Lawson et al., 2005). Although SP-B and SP-C possess a very different molecular structure, 
they are both lipid membrane associated and thus probably perform their surface activity in a 
concerted manner. Together they improve surfactant activity, in particular interfacial adsorption, film 
stability and its re-spreading abilities (Cruz et al., 2000;Serrano and Perez-Gil, 2006;Wang et al., 
1996) and it has been shown that these roles are particularly relevant at extensive lung expansion and 
relaxation during periods of high ventilatory demands (Almlen et al., 2008). 
 
It has been argued that surfactant in its original, compact and lamellated structure is not able to 
adsorb at the ALI directly and, consequently, needs to be ‘activated’. Theories on the kind of 
activation focused on an enzymatic cleavage process (convertase) in combination with exposure of 
LBPs to mechanical forces acting at the ALI (Gross and Schultz, 1990) and a Ca
2+
/SP-A promoted 
unraveling and rearrangement of the surfactant PL-bilayers into a three-dimensional lattice structure 
(tubular myelin) feeding single PL molecules into an expanding film (Gil and Reiss, 1973). 
According to another hypothesis, surfactant is activated by the deformation during its passage 
through the fusion pores (Kliewer et al., 1985). Up to now, however, an experimental proof of either 
concept is still missing. We instead propose that LBPs are structurally pre-assembled in a way that 
enables a direct and rapid adsorption at an ALI in the absence of any metabolic or structural 
intermediate. Upon surface contact, the small hydrophobic surfactant proteins SP-B and SP-C are 
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acting, probably in concert and probably on the outermost surfactant lipid layer, as a molecular 
trigger to unravel the compact LBP structure and to initiate the initial stage of surface film formation. 
This model also implies a decisive role of interfacial tension as the essential driving force in this 
process. 
 
Results and Discussion 
 
Characterization of AT II cells and collected LBPs 
As demonstrated by confocal microscopy, primary cultures of AT II cells, grown for 48h on plastic, 
exhibit a typical morphology. They contain a large number of surfactant storage vesicles (=LBs), 
which are stained by fluorescence targeted against the ATP-binding cassette transporter A3 
(ABCa3), a specific LB membrane marker (Fig. 1, red) (Yamano et al., 2001). As indicated with 
arrows, intracellular LBs contain substantial amounts of surfactant proteins SP-B and SP-C. Both 
proteins show a particular granule-like packing (Fig. 1, green), which is bordered by the vesicle’s 
limiting membrane (Fig. 1, red). To our knowledge, this is the first demonstration of the distribution 
of SP-B and SP-C in LBs of primary ATII cells using high resolution confocal microscopy. 
 
Highly pure ATII cell cultures were stimulated with a solution containing 100µM ATP + 300nM 
PMA. Thereafter, cell supernatants containing released LBPs in suspension were harvested and 
immediately frozen at -20°C. The PL concentration of the collected samples was evaluated as 
previously described (Hobi et al., 2014;Ravasio et al., 2008;Ravasio et al., 2010). Western Blots 
(n=3) were performed under non reducing conditions. As shown in Fig. 2. the collected samples 
contain significant amounts of SP-B and SP-C. Detected band sizes are comparable to samples from 
rat bronchoalveolar lavage (BAL), serving as a positive control. In vivo the amount of SP-B and SP-
C is very small, indeed less than one percent of the entire surfactant mass. This small fraction, 
though, plays a crucial role in surfactant function (Casals, 2001;Serrano and Perez-Gil, 2006). In 
summary, we suggest that with respect to the molecular content and lipid packaging, freshly 
collected LBPs are the most original and authentic source of pulmonary surfactant currently used for 
surfactant studies. 
 
Localization of the hydrophobic surfactant proteins 
We analyzed immunofluorescence of the hydrophobic surfactant proteins on cell-attached LBPs. In 
this transitional state, which is neither purely intra- nor extracellular, LBPs are partially exposed to 
the extracellular fluid and partially trapped by a restricted diameter of the exocytotic fusion pore 
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(Haller et al., 2001). Thus, in a sense, LBPs are mechanically arrested and can be used for detailed 
microscopic investigations. To activate exocytosis, AT II cells have been stimulated with 100µM 
ATP for 15 min (Haller et al., 2001). Subsequently, the cells have been washed and exposed with 
primary rabbit anti SP-B (aSPB) or rabbit anti SP-C (aSPC) and finally with secondary anti rabbit 
Alexa488 conjugated antibody. All stainings were done on living cells, under cold conditions to 
prevent unspecific binding or intracellular antibody (AB) uptake by endocytosis.  First, cell attached 
LBPs were identified by a 2 min time lapse protocol using transmitted light (Fig. 3, 1
th 
and 2
nd
 
column, BF). LBPs that protrude out of fused LBs are noticeable by irregular movements of their 
extracellular portion (Haller et al., 2001).  In parallel, AB staining was recorded by exciting 
Alexa488 fluorescence (Fig 3, 4
th
 column, aSPB and aSPC). Thereafter cells were additionally 
stained with extracellular FM1-43, a lipid membrane probe well documented to be suited for staining 
cell attached LBPs (Fig. 3, 3
rd
 column, FM 1-43) (Haller et al., 1998). Examples for cell attached 
LBPs are indicated with blue arrows. Negative controls, lacking primary ABs, proved the specific 
binding of the applied ABs (Fig. 3, n.c., Movie S1_neg.ctrl). Images show a specific antigen staining 
of SP-B and SP-C in freshly released but still plasma membrane-attached LBPs (Fig. 3 aSPB and 
aSPC; Movie S2_SPB and Movie S3_SPC). In summary these findings demonstrate that, 
immediately after LB fusion and onset of LBP release, SP-B and SP-C epitopes are freely accessible 
to the antibodies from the extracellular side. This can be taken as a first evidence of a peripheral 
location of the two proteins on LBPs. 
 
 By using scanning electron microscopy (SEM) we aimed at a closeup of the LBPs surface and the 
specific protein location. Partially extruded LBPs in the same transitional state as above were stained 
with aSPB and aSPC followed by an immunogold (25 nm) labeling. As shown in Fig. 4, LBPs stay 
in compact, ballon-like aggregates during release. Gold particles were visualized with backscattered 
electrons (Fig. 4 right) and specifically target SP-B on the outmost LBP membrane protrusions (inset 
and arrows). Upon now, few EM studies exist focusing on SP localization. By using immune-TEM, 
Brasch et al. described that in human cells SP-B is restricted to a so-called projection core, a 
peripheral structure of randomly arranged stacks of densely packed membrane segments (Brasch et 
al., 2004). This finding has been confirmed by Ochs et al. in 2010 using a combination of in-situ 
fixation, cryopreparation and colloidal gold immuno-TEM (Ochs, 2010). Interestingly, in LBs of rat 
lungs, lacking such a projection core, SP-B was more evenly distributed over the lamellae (Brasch et 
al., 2004) and similar observations exist for the mouse (Liou et al., 1996). Despite these supportive 
results, these TEM studies do not allow to conclude that SP-B is also located at the external face of 
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extruded LBPs. To our knowledge, this is the first demonstration of surface localization of SP-B in 
fully intact LBPs. 
In contrast, immunogold staining failed to detect SP-C despite several experimental replicates. 
However, this finding would be consistent with recent data on SP-C location and orientation in lipid-
bilayers (Pastrana et al., 1991;Vandenbussche et al., 1992). These studies describe that the 
monomeric SP-C molecule is completely inserted into the membrane interior except for the N-
terminal residue, which barley projects from the strongly negatively charged lipid surface (Roldan et 
al., 2015;Vandenbussche et al., 1992). In comparison, native SP-B is more positively charged than 
SP-C, and SP-B was recently modelled to build huge complexes up to 10nm, which significantly 
protrude out of the plane of the lipid layers (Olmeda et al., 2015). It has been proposed that SP-B/SP-
C complexes form pores in surfactant membranes that are smaller than those formed by SP-B alone 
(Parra et al., 2013). It is therefore also conceivable that bare antibodies are small enough to get 
access to SP-C but not once they are conjugated to bulge gold particles.  
 
Functional SP-B and SP-C are critical for rapid interfacial adsorption of LBPs 
Few years ago, our lab developed a method for measuring phospholipid surface film formation in the 
fluorescence mode of a multiplate reader instrument (Ravasio et al., 2008). In comparison to 
conventional techniques such as Langumir-Whilhemy surface balance and captive bubble 
surfactometry, this assay allows simultaneous kinetic analysis of the extremely low surfactant 
quantities (ng range) with which we are confronted in this study (Danhaive et al., 2015;Hobi et al., 
2014;Ravasio et al., 2008). Here, we used this assay to test whether blockage of SP-B or SP-C with 
rabbit aSPB or aSPC leads to a substantial change in LBPs adsorption. For that we prepared different 
AB solutions in a concentration range between 2 to 100 nM. First we measured the transparent 
control and tested if ABs affect Bodipy-PC fluorescence. This was not the case (Fig. 1S, Inset). 
Furthermore, we used rabbit anti-IgG (aIgG) to verify possible surface interactions of the ABs by 
themselves. In line with recent publications (Danhaive et al., 2015;Hobi et al., 2014), we defined the 
maximum fluorescence value, which reflects the steady state surfactant film formation after maximal 
adsorption, as Max. Additionally, we calculated the Slope (=ΔRFU/min) of the initial adsorption, 
which is a critical parameter to evaluate the adsorption dynamics (Fig. S1). As shown in Fig. 5A, a 
100nM aSPB (n=6) or aSPC (n=6) solution had a dramatic effect on adsorption kinetics and 
surfactant film formation (Kinetics) of freshly collected LBPs. Blockage of either protein therefore 
seem to prevent rapid initial adsorption to reach highest Max (Fig. 5B and C, P*<0.05, P**<0.01, 
P***<0.001). Furthermore, already very low AB concentrations (10nM and 20nM) showed a small 
tendency of Max inhibition (Fig. 5B) and a significant reduction of the initial slope (Fig. 5C). The 
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results are consistent with studies describing that both, SP-B and SP-C, promote lipid adsorption at 
the ALI. Moreover, it is suggested that these two proteins might have a combined or even synergistic 
function for optimal surface activity (Klenz et al., 2008;Parra and Perez-Gil, 2015;Schürch et al., 
2010). We tested this hypothesis by adding aSPB and aSPC simultaneously. The result was a highly 
significant and dose-dependent functional loss of LBPs (Fig. 5 SP-B + SP-C, n=10-14). Max and 
Slope of aSPB+C treated samples were significantly reduced in comparison to the negative controls 
(aIgG and w/o). Furthermore, regarding Max, a combined application of aSPB+C (2-20nM) showed 
a strong and highly significant reduction in comparison to aSPB or aSPC alone (indicated with 
P
#
<0.05, P
##
<0.01, P
###
<0.001 against SPB (B) and SPC (C)). In comparison with previous studies, 
these results confirm that SP-B and SP-C are both important for rapid and maximal surfactant 
adsorption. We found that the functional loss of one protein might still permit partial activity by the 
other protein, suggesting that the two proteins might not only act in an additive but even in a 
cooperative way. This interplay is apparently less important for the initial phase of LBPs adsorption 
(Fig. 5 Slope) than for reaching highest adsorption capacity (Fig.5 Max). Recently, the same 
adsorption assay was used to distinguish the film formation properties of therapeutically used 
surfactants, and it was noted that the amount of SP-B in the samples critically affects surfactant film 
formation. The amount of SP-C, however, was not tested in these studies. Furthermore, adding SP-B 
and SP-C into extracted phospholipids from healthy infant resulted in an additive 6–fold increase in 
Max (Danhaive et al., 2015). 
 
Blockage of hydrophobic surfactant protein directs LBPs inactivation 
We previously demonstrated by the inverted interface microscopy (Haller et al., 2004;Hobi et al., 
2012;Ravasio et al., 2010) that freshly released LBPs spontaneously and rapidly disintegrate when 
they contact the ALI, creating an interfacial film with a solid character and a three-dimensional 
complex topography (Haller et al., 2004;Ravasio et al., 2010). Importantly, the high γ at a clean 
interface (γ = 72mN/m) was the driving force for LBP transformation, and it constantly decreased to 
values ~30 mN/m with the continued incorporation of new material (Bertocchi et al., 2005;Haller et 
al., 2004). Hence, as the driving force for LBPs adsorption ceased, LBPs remained untransformed 
and clustered beneath the ALI.  
In this study we used the inverted interface technique to investigate LBPs transformation in the 
presence of the respective blocking ABs. We have summarized the critical steps of the experimental 
protocol in Fig. 6 and refer for a detailed explanation to previous publications (Bertocchi et al., 
2005;Haller et al., 2004;Ravasio et al., 2011). Fig. 6A sketches the heated chamber filled with 
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experimental solution. FM1-43 preloaded LBPs were gently pipetted into that solution and reach the 
ALI by slow sedimentation. Upon random interface contact (Bertocchi et al., 2005;Haller et al., 
2004;Ravasio et al., 2010) LBPs spontaneously disintegrate (=transform, Fig. 6B; Movie S4A and 
S4B) and spread into a surface film (Ravasio et al., 2010). Here, we investigated these events in the 
presence of aSPB and/or aSPC by using two different approaches. In the first one (protocol A), we 
filled the pre-heated chamber with bath solution (37 °C) containing different concentrations of aSPB 
and aSPC (2nM-100nM). Subsequently, FM 1-43 loaded LBPs were added. To disclose a possible 
interfacial effect of unbound AB, we pre-incubated LBPs with ABs (1µM to 20nM for 2h) and 
removed unbound ABs by a repeated, careful washing before adding them to the chamber (protocol 
B). In both protocols we used untreated LBPs (w/o) and anti-rabbit IgG (aIgG) in the equivalent 
concentrations as a negative control. The sedimentation curves of Fig. 6C are representative for the 
total number of LBPs that arrived at the interface during the first 10 min. No significant difference 
could be observed between protocol A (52±2, n=20) and protocol B (50±2, n=20). Also, AB 
treatment had no effect on the sedimentation rates or the shape/size of the LBPs. 
The analysis of LBP transformation is shown in Fig. 7. When using protocol A, LBPs showed an 
average transformation rate of 19 ± 3 (w/o, n=11) or 20 ± 2 (100nM aIgG, n=17) under control 
conditions. Presence of aSPB or aSPC, even in the smallest concentrations (2nM), lead to a very 
strong inhibition and dose-dependent effect on the transformation rate at the ALI (Fig. 7A; n=10-15). 
Furthermore, we also tested aSPB and aSPC together. The effect was a cumulative one. In 
comparison to the individual application of aSPB or aSPC in small amounts from 2nM-20nM, the 
combined application (aSPB+C) resulted in a more than 50% decline of LBPs adsorption (Fig. 7A; 
aSPB+C, n=10). These microscopic data are consistent with the quantitative data performed with the 
adsorption assay in Fig. 5. 
In protocol B (Fig. 7B), LBPs without AB (w/o) or incubated with 1µM aIgG showed a mean 
disintegration of 23±2 LBPs or 20±1 LBPs within 10 min, respectively. Treatment with 1µM aSPB 
or aSPC significantly reduced transformation rate to less than 5±2 LBPs. Less AB concentrations 
between 10-100nM had a smaller but still significant effect (Fig. 7B, n=10-12).  Similar as in 
previous experiments, the combined application of both ABs (aSPB+C) lead to a further reduction of 
LBP adsorption. In particular, treatment with 10nM aSPB+C lead to a transformation rate of 5±1 
LBPs in comparison to 13±2 LBPs (n=10) and 20 ±2 LBPs (n=10) by using aSPB and aSPC 
individually. Both protocols lead to highly comparable results. The slightly weaker effect in protocol 
B could be explained by antibody washout leaving some epitopes unaffected. Even more likely, 
during surface contact and beginning particle disintegration, additional epitopes could become 
accessible, particularly those in SP-C, which cannot be blocked using protocol B.  
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Many studies described a surface activity of highly concentrated protein and AB solutions by 
themselves, a factor that could potentially confound our interpretations (Holm et al., 1985;Mahler et 
al., 2009;Taeusch et al., 2005;Zasadzinski et al., 2005). However, the AB concentration used in our 
first approach (Protocol A, 2nM-100nM) was much lower, than the concentrations reported to cause 
a significant effect on surface pressure (Herting et al., 1999;Mahler et al., 2009;Taeusch et al., 2005). 
By pre-treatment of LBPs with AB followed by washout of unbound AB (Protocol B) we can rule 
out this possibility almost entirely. Furthermore, we also used IgG as a negative control in the same 
concentration as aSPB and aSPC without observing an effect. Finally, the additive effect of aSPB 
and aSPC strongly suggests a specific interaction of the ABs with the LPBs surface.  
 
Change in local surface pressure reflected by LBPs motility 
The unpacking of LBPs, whether caused by physical, chemical or other factors, is an essential 
prerequisite for lipid insertion into the ALI. Probably the most striking of these events is the 
immediate loss of LBP structure when they contact an ALI, delivering a bulk of material into small 
surfaces patches. We observed that during these patch formations, all other discernable surface 
structures, including non-adsorbed and only partially transformed LBPs, are subject to rapid lateral 
motions and hypothesize that they are due to a liquid flow generated by local surface pressure 
(tension) gradients (Marangoni-effects). This is evidenced by the second observation that the mean 
velocity of particle movement gradually ceased with ongoing LBP conversions and eventually comes 
to a halt when γ- gradients are abolished, after formation of a continuous film (Bertocchi et al., 
2005). In that case, like in a pure surfactant-free solution, the velocity of fluorescent beads embedded 
onto our inverted ALI, turned out to be zero (Ravasio et al., 2010). Therefore, we exploited this 
phenomenon as a probably very sensitive indicator for the insertion of surface active material out of 
transformed LBPs. Lateral particle mobility was measured and traced by a semi-automated 2/3D 
single-particle tracking tool from the mosaic group (Sbalzarini and Koumoutsakos, 2005). The 
program detects all spot-like surface structures of a defined cut-off for fluorescence intensity and 
pixel size (see Fig. 8, A-C and Movie S5). As shown in control conditions, lateral velocity (µm/sec) 
is high during the first 10 initial LBPs adsorption events (0.67µm/sec, n=4 representative tracks) and 
slowed down, with an exponential decay, to 0.35 µm/sec during further LBP adsorption (Spearman’s 
correlation coefficient = -0.93; P < 0.0001, Fig. 8C). As shown in Fig. 8D, when using protocol B the 
average particle velocity within the first 10 min was 62 ± 3 µm for control LBPs (w/o). Increasing 
concentrations of aSPB or aSPC showed a highly significant reduction of lateral particle motility in 
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both protocols (Fig. 8D (protocol B) and Fig. S2 (protocol A)). Furthermore, combined application 
of both ABs leads to a further reduction of LBPs velocity close to zero (Fig. 8D and S2). As we 
expected, AB induced inactivation of the unpacking of LBPs resulted in a significant decline in 
lateral velocity, most likely due to the lack of insertion of surface active material into the ALI. During 
ongoing LBP adsorption, γ typically falls from ~70 to ~30 mN/m (Bertocchi et al., 2005) causing 
different driving forces for LBP disintegration. To study the AB effects at a high γ, we analyzed 
particle velocity at the initial adsorption events (<30 sec). The results (Fig. 8E) showed no blocking 
effect at low individual AB concentrations but still a dramatic, even synergistic effect at combined 
AB application. This result could indicate that the function of each individual protein is less 
prominent at high γ, but an absolute requirement at those low γ values that normally exist in the lung 
(~ 30 mN/m (Schurch et al., 1976)). It therefore seems that interplay between both proteins is 
especially essential to reach highest material insertion (i.e. highest surface pressure) under moderate 
γ (low driving forces). 
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Summary and Conclusion 
 
In summary, blocking SP-C and SP-B on the surface of freshly released LBPs dramatically disrupts 
their functionality at an ALI, demonstrated by the absence of formation of surface films concomitant 
with an accumulation of unexpanded LBPs. This finding eventually provides the molecular 
mechanism for the interpretation of in vivo experiments conducted as early as twenty years ago. In 
these studies, it has been shown that application of aSPB into the lungs of healthy rabbits and mice 
lead to a lethal respiratory failure as early as 15 min after intratracheal instillation. Specifically, it has 
been shown that blocking SP-B lead to disease syndromes similar to those seen in the course of 
ARDS associated with striking fall in lung-thorax compliance, vastly elevated minimum γ and to a 
massively retarded surfactant adsorption combined with alveolar collapse. These severe pathological 
and histological effects were only observed in aSPB treated animals but not in the IgG control 
groups, disclosing an immunological effect (Fujita et al., 1988). Suzuki et al. and Fujita et al. 
reported an accumulation of “unexpanded lamellar bodies” in the alveolar lining fluid and suggested 
an interference with their normal ability to transform into a surface active film (Fujita et al., 
1988;Suzuki et al., 1988). These lamellar bodies also contained an electron dense material which 
obviously did not disintegrate in the alveolar fluid. Importantly, though, none of these early studies 
and, to our knowledge not even up to now, attempted to test for an aSPC effect although the 
important role of this protein in surfactant film formation has long been known.  
Here, we show that the hydrophobic surfactant proteins SP-B and SP-C are not only enclosed in 
intracellular surfactant (LBs) but also exposed in the release particles (LBPs). SP-B and SP-C 
localization is evidenced by immunofluorescence of extruding LBPs and by the strong effect of ABs 
on their adsorptive capacity at an ALI. We hypothesize that these proteins are forming large 
hydrophobic pores that interact with, or that are target of, the forces acting at an ALI. The recent 
structure reported for a large SP-B ring-shaped oligomer supports such a concept (Olmeda et al., 
2015). Although the kind of action affecting the interfacial behavior of SP-B oligomer is obscure, we 
propose the following possible models: SP-B-based ring-shaped oligomers could be located at the 
outermost surfactant layer in LBPs, which previously to exocytosis could be in contact with the LB 
limiting membrane, where the ATP-driven ABCa3 pump is in charge of importing surface active 
lipids (Perez-Gil, 2008;Yamano et al., 2001). The progressive action of ABCa3 during LB 
biogenesis could accumulate lipids to generate a highly packed “energized” state with particular 
order and hydration properties that have been recently described (Cerrada et al., 2015) (see model in 
Fig. 9). Upon secretion, the highly packed activated state is preserved (Cerrada et al., 2015) enclosed 
into the now limiting membrane of LBPs, where SP-B/SP-C structures are exposed to the 
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extracellular environment. The eventual contact of SP-B machinery, at the surface of secreted LBPs, 
with the ALI could trigger a conformational transition opening, or disassembling, the ring, which 
would then liberate a rapid flow of surface active lipids into the interface, possibly facilitated by the 
sudden liberation of the high internal pressure of LBPs, generated by the primary action of ABCa3 
but maintained by a closed conformation of the SP-B ring. Binding of aSPB antibodies to those SP-
B-triggered LBP surface machineries could block the surface-activated opening mechanism and 
prevent LBP spreading (see Fig. 9, right panel). The machinery could be also blocked by aSPC 
antibodies, if SP-C could also take part in the SP-B gating structure. We have determined that SP-C 
reduces the size of pores created in membranes by SP-B (Parra et al., 2013), which could be 
indicative of a direct SP-B/SP-C contact. The combined effect of aSPB and aSPC antibodies to block 
LBP interfacial adsorption could mean that the gating machinery exposes both SP-B and SP-C 
epitopes, either simultaneous or sequentially, and that the possibility of blockage at both sites 
increases the inhibitory capacities of combined antibodies. Irrespective of the real molecular mode of 
action, which should still be investigated, the hydrophobic surfactant proteins B and C have a 
combined essential role in the unpacking of the large LBPs and in promoting a rapid delivery and a 
bulk transfer of surface active materials onto an ALI. Disturbances in this process may well explain 
the inhibitory effect of some substances (cholesterol, meconium, serum components etc. (William et 
al., 1999)) but also the dramatic pulmonary consequences that has been documented by former in-
vivo animal experiments. 
 
Materials and methods 
 
Reagents  
Unless otherwise specified, all reagents have been purchased from Sigma (Germany) and Life 
Technologies (Germany). Elastase from porcine Pancreas for cell isolation was purchased from 
Elastin Product Company (US). For bath solution we used standard Ringer Solution containing (in 
mM): 140 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES, pH 7.4. Rabbit mature anti-SPB (WRAB-
48604) and rabbit mature anti-SPC (WRAB-76694) were purchased from Sevenhills Bioreagents 
(US). IgG (Cat. # 31235) from Life Technologies was used as neg. ctrl for the functional studies. 
Rabbit antibodies were protein A purified and concentrations were verified with an Easy-Titer™ 
rabbit IgG Assay Kit (Life Technologies, Germany). For the functional studies antibodies were 
further diluted into bath solution to assay dependent concentration.  
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Surfactant preparations and quantification 
LBPs were harvested from the supernatants of purified rat AT II cells grown on petri dishes (Ø 10 
cm) in high density. AT II cells were isolated from Sprague-Dawley rats as described elsewhere 
(Haller et al., 1998). After two days in culture, these cells were washed two times with PBS and cells 
were stimulated for 4 h at 37 °C in 4 ml bath solution containing ATP (100 μM), PMA (300 nM) and 
Ionomycin (1 µM) supplemented with antibiotics as previously described. After stimulation, 
supernatants containing exocytosed surfactant rich in LBPs were collected filtered and stored at -20 
°C until use. Subsequently phospholipid concentration of collected LBPs was measured by a lipid 
chloroform/methanol extraction protocol followed by choline determination using a coupled 
enzymatic reaction according to published references, with slight modifications, which are precisely 
explain in our recent publications (Hobi et al., 2014;Miklavc et al., 2012;Ravasio et al., 2008). 
 
Fixed cell immunofluorescence  
For immunofluorescence staining, ATII cells after isolation were seeded on 8-well ibidi dishes 
(IBIDI Gmbh, Germany). After two days cells, were washed twice in prewarm PBS (pH 7.4, 
Biochrom, Berlin, Germany), subsequently fixed for 20 minutes in 4% paraformaldehyde in PBS and 
permeabilized for 10 minutes with 0.2% saponin and 10% FBS (Thermo Scientific, Bonn, Germany) 
in PBS. Cells were subsequently stained for 30 min on room temperature with 1:300 diluted primary 
antibodies (mouseABCa3 (Abcam ac24751), rabbit aSPB (WRAB-76694), rabbit aSPC (WRAB-
48604)) in PBS, 0.2% saponin and 10% FBS. Followed by four times washing with PBS and 
incubation with 1:500 diluted secondary antibody goat anti-mouse-Alexa568 (Life Technologies) 
and  goat anti-rabbit-Alexa488 (Life Technologies) and 0.5 µg/ml Hoechst 33342 in in PBS, 0.2% 
saponin and 10% FBS. Unspecific binding of was precluded by direct application of secondary-
Alexa antibodies. Images were taken on an inverted confocal microscope (Leica TCS SP5, Leica, 
Germany) using a 63× lens (Leica HCX PL APO lambda blue 63.0× 1.40 NA Oil UV). Several z-
stack images for the blue (Hoechst 350), green (Alexa Fluor 488), red (Alexa Fluor 568) channels 
were taken in sequential mode using appropriate excitation and emission settings. Further image to 
montage processing was done in Fiji (NIH, United States) and final figure processing in Adobe 
Photoshop.  
 
Electrophoresis and Western blot 
For electrophoresis testing LBPs and rat bronchial lavage (BAL) samples were concentrated by 
ultracentrifugation (Ravasio et al., 2010). SDS/PAGE was performed under non reducing conditions 
in 16% acrylamide gels. Transfer of proteins to PVDF membranes (Bio-Rad, Spain) was performed 
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in a wet transfer system at 300 mA for 1 hour. 32µg total phospholipid mass was loaded in to the gel 
for detecting SP-B and 16µg for SP-C. Primary antibodies from Sevenhills (US) were diluted to 
1:3000 for aSPB and 1:7000 for aSPC. Secondary antibody swine anti rabbit HRP-conjugated from 
Dako (Denmark) was diluted to 1:10000. Blot were analyzed in the ImageQuant LAS 4000 device 
(GE Healthcare, Germany) and further processed in Fiji and Adobe Photoshop. 
 
Life cell Immunofluorescence 
ATII cells were seeded in 8-well ibidi dishes (Ibidi GmbH, Germany) and used for experiments 2 
days after isolation. Cells were stimulated with 100µm ATP for 15 min at 37°C. All stainings were 
done on living cells, under cold conditions to prevent unspecific binding or intracellular AB uptake 
by endocytosis, without using fixation or permeabilization buffers. Subsequently cells were kindly 
washed two-times with ice-cold bath solution, followed by incubation with 1:100 rabbit aSPB and 
aSPC in bath solution for 30 min at 4°C. Afterwards cells were again kindly washed four times with 
ice cold bath solution. Further incubation with secondary donkey anti-rabbit Alexa488 antibody from 
Life Technologies was followed by careful 4 times washing step with bath solution. Images were 
taken under the iMic microscope (Till Photonics, Germany) with a 60x 1.35 NA Oil objective and 
appropriate filter set. Firstly, one movie was made for 2 min by making a snapshot in brightfield 
light (BF) and fluorescence light (excitation wavelength 488) every 3 seconds. After the first image 
acquisition FM1-43 was added to the bath solution (end concentration 1µM), which indicates 
substantially fused LBPs. Another image acquisition for FM1-43 fluorescence staining was taken for 
2 min. Further Image to Montage and movie processing were done in Fiji (NIH, Bethesda, United 
States) and final figure processing in Adobe Photoshop.  
 
Electron Scanning Microscopy 
Freshly isolated AT II cells were seeded on glow discharged, carbon treated and 4h fibronectin 
coated sapphire discs (3 mm in diameter, 160 µm thick, Engineering Office M. Wohlwend GmbH, 
Sennwald, Switzerland). After two days cell were gently washed two times with warm bath solution 
and subsequently stimulated with 100µM ATP and 300nM PMA for 15 min at 37°C.Primary 
antibodies rabbit aSPB or aSPC were diluted 1:100 in PBS, incubated at 4°C for 45 min and 
subsequently AB was carefully washed out with repeated washing steps. Afterwards, secondary 
25nm-goldlabeled anti rabbit-AB (Aurion, Netherland) was diluted 1:50 in PBS + 0,1% FCS and 
applied for 30 min, followed by gentle washing steps. After fixation with 2.5 % glutaraldehyde (in 
PBS, phosphate buffer and 1% saccharose) for several hours at room temperature the samples were 
dehydrated in increasing concentrations of propanol and then critical point dried with carbon dioxide 
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as translation medium (Critical Point Dryer CPD 030, BalTec, Principality of Liechtenstein). Finally, 
the cells were coated with 7 to 10 nm of carbon using a Baf 300 (BalTec, Principality of 
Liechtenstein). Samples were observed on a FE-SEM (Hitachi S-2500) operated at 10 kV 
acceleration voltage. Immuno-gold particles were visualized with backscattered electrons, surfaces 
with the secondary electron signal (Walther and Mueller M, 1985). 
 
Microplate reader based adsorption Assay 
BODIPY-PC was dissolved in DMSO to yield a concentration of 1 mg/ml. LBPs were stained by 
incubation with BODIPY-PC at 37 °C for 2h to obtain a final molar ratio of 4% (dye/surfactant) 
(Ravasio et al., 2008). Experiments were performed using an assay system specifically designed to 
evaluate interfacial adsorption of LBPs. It provides a direct readout of the amount of surfactant 
reaching the interface but also of the material, which stably associates with the forming interfacial 
film. This method is described in detail in a previous publication (Danhaive et al., 2015;Hobi et al., 
2014;Ravasio et al., 2008). Briefly, the wells of a 96-well microplate (sterile, flat, transparent Cat.# 
655185, Greiner, Germany) were filled with 100 µl of a solution containing 5 mg/ml Brilliant Black 
as a photoquencher. The plate was inserted into the microplate reader (TECAN GENios Plus, 
Switzerland) and all measurements with following standard settings: fluorescence top reading mode 
number of (485 ± 9 nm excitation and 540 ± 9 nm emission), flashes 3, lag time 0 µs, and 
integrations time 1000 µs. Firstly, unspecific effects of antibody solution (aSPB, aSPC, aIgG) were 
tested by measuring 4% BODIPY-PC loaded LBPs in the respective transparent bath solution (Fig. 
S1, Inlet). Secondly, one background measurement (Brilliant Black only), was obtained. Thirdly, the 
96-well plate was moved out and 0.5 µg of 4% BODIPY-PC (dye/surfactant) labeled surfactant was 
injected into the bulk solution of the wells. Thereafter, a kinetic cycle of fluorescence measurements 
was started for one hour (cycle time = 1 min, orbital shaking = 30 s). Fluorescently labeled surfactant 
distributed within the well by orbital shaking, and was finally irreversibly adsorbed into the ALI, 
where the fluorescence signal was detected and quantified kinetically. Data were normalized with 
respect to the transparent values and by subtracting the background. For illustration of the kinetic 
curve (=kinetics) we defined the maximum fluorescence value, which reflects steady state surfactant 
film formation after maximal adsorption as Max (Fig. S1) and the initial adsorption events are 
reflected as Slope (Fig. S1). Microsoft Excel and GraphPad Prism were used for background 
correction, student’s t-test analyzing, Max and Slope calculation, and the final graph design.  
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Life cell inverted interface setup 
For the microscopic experiments, we used our inverted interface setup, slightly modified for the 
needs of the experimental requirements (Hobi et al., 2012;Ravasio et al., 2010). The chamber is 
made of stainless steel (material description: 1.4542), which is highly resistant to corrosion, heat and 
acidity. The bottom is covered with a nanocoating, made of a glass-ceramic polar Si-O network with 
emedded nano-particles to avoid wetting of the chamber bottom. These special characteristics are 
important to establish a clean interface, which is kept in the 200µm capillary (=approx. same area as 
an alveolus) by adhesion and surface tension (Hobi et al., 2012;Ravasio et al., 2011)). 
As shown in the sketch of Fig. 6, heated chamber was prefilled with warm Ringer solution and then 
LBPs pre-loaded with 6µM FM1-43 (3.6µg/ml) were gently pipette in the chamber. LBPs sediment 
due to gravity forces and upon interface contact they disintegrate. These dynamic adsorption events 
were imaged over time, under the inverted microscope (Axiovert from Zeiss equipped with a 40x 
LD-Achroplan, NA 0.6 air objective from Zeiss, and a cooled CCD camera, controlled by 
TiLLVison software, (Ravasio et al., 2011)). Timeseries were performed over 10 min with a 
snapshot each 5 seconds using fluorescence light with an excitation wavelength 488 nm, and 
appropriate filter set. Two different protocols were established for the AB application. In the first 
protocol FM1-43 stained LBPs were pipetted into chamber, prefilled with warm Ringer solution 
containing different concentrations of AB (2-100nM; direct antibody treatment= Protocol A). In a 
second protocol, LBPs were preincubated with AB solution (10nM-1µM) for 2 h, followed by gentle 
centrifugation steps (800g) for washing out the unbounded AB (preincubation antibody treatment= 
Protocol B). In initial studies we used respective IgG Fab fragments (Pierce™ Fab Preparation Kit, 
Thermo Scientific, Germany) to preclude any antibody self-assembly.  Afterwards, LBPs were 
loaded with 6 µM FM1-43 and pipetted into chamber containing Ringer solution and timeseries 
acquisition was started. The total number of transformed LBPs was determined by manual evaluation 
in ImageJ. Further data analysis and column graph design were performed in Microsoft Excel and 
GraphPad Prism.  
 
LBPs velocity 
To determine the two dimensional movement distance and the average velocity of LBPs on the liquid 
surface the ETHZ MOSAIC Particle Tracker 2D/3D plugin for ImageJ 
(http://www.mosaic.ethz.ch/Downloads/ParticleTracker, (Sbalzarini and Koumoutsakos, 2005)) was 
used with following standard settings: Radius 3, Cutoff 3.0 and Per/Abs 0.1. Particle detection 
efficiency of the plugin was verified manually for every data set and for each movie 10 tracks were 
extracted into MS Excel for further processing. The robust plugin automatically records X and Y 
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values from tracked particle in each image. X and Y data were exported into MS Excl.  The covered 
pixel distance of a particle between two time frames was analysed as followed:  
𝑥 = [√∆x2 + ∆y2]. The total velocity for initial adsorption (<30 sec) and over 10 min were 
calculated by summation of the single frame distances and pixel were converted to µm.  LBPs 
velocity over 10 min of different conditions were compared to neg. ctrl (w/o). 
 
Statistics  
Image analysis and data presentation 
Images were analyzed using iMic Online Analysis and Tillvision (Till Photonics, Germany), Fiji 
(NIH, Bethesda, United States). Microsoft Excel and GraphPad Prism 5 were used for Max and Slope 
calculations, background correction, statistics, and graph design. All data are presented as mean ± 
SEM with following P value assignments: Asterisk (*) was used to indicate significance against the 
corresponding control conditions (aIgG and w/o) P*<0.05, P**<0.01, P***<0.001) and P
#
<0.05, 
P
##
<0.01, P
###
<0.001 if combined application of both ABs was significantly different to aSPB or 
aSPC alone in the respective concentration.  
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Fig. 1 
 
 
FIGURE1 SP-B and SP-C are highly expressed in 48h cultured, primary ATII cells. The red 
channel indicates the lamellar body (LB) specific marker ABCa3 and the green channel the 
expression of SP-B (upper row) and SP-C (lower row) within the lumen of LBs. Areas of 
enlargement are indicated by the arrows. Cells in this phenotypic state have been used for the 
collection of Lamellar Body-like Particles (LBPs), exocytosed by the ATII cells after agonist 
stimulation. Scale bar: 5 µm. 
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Fig. 2 
 
FIGURE2 Freshly collected LBPs contain SP-B and SP-C. Left: Under non-reducing conditions, 
samples (LBP) demonstrate a specific SP-B band with mobility corresponding to 18 kDa, indicative 
for a covalent SP-B dimer. A comparable band can be seen in rat bronchoalveolar lavage (BAL) 
serving as positive control. Right: Specific SP-C band in the test sample and in BAL positive control. 
Presented Western blots are representative for n=3. 
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Fig. 3 
 
 
FIGURE3 SP-B and SP-C are located on extracellular LBPs surface. AII cells have been 
stimulated with ATP and subsequently stained with primary and secondary ABs. Fused vesicles 
release LBPs as protrusions (arrows) out of the cell membrane, seen in brightfield (BF) and by 
extracellular application of FM1-43, a lipid membrane fluorescent probe not penetrating intact 
membranes (FM 1-43). All stainings have been performed in living cells without using fixation or 
permeation buffer at 4° C. Negative controls (n.c.; Movie S1) without aSPB or aSPC (upper panel) 
precludes unspecific AB binding. Specific signals were obtained with primary AB (aSPB, aSPC; 
Movies S2 and S3). Images are representative for n=5. Scale bar: 10 µm.  
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Fig. 4 
 
 
FIGURE4 SEM of cell attached LBPs. Scanning electron microscopy of stimulated ATII cells show 
LBPs as ballon-like protrusions out of the plain of the cell membrane. Immunogold label for SP-B 
was specific (top, right) and co-localizes predominantly to wart-like surface structures on the 
outermost LBP membranes (top left, inset and arrow).  SP-C was not detectable (bottom, left and 
right). 
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Fig. 5 
 
FIGURE5 Adsorption Assay of fluorescently labeled LBPs. LBPs were treated with aSPB or aSPC 
(2nM-100nM) separately or in a 1/1 combination (aSPB+C=2nM-100nM). Bath solution (w/o) and 
100nM aIgG served as negative controls. A: Adsorption kinetics. 100nM aSPB or aSPC had a 
dramatic effect on LBP adsorption (= surface film formation; n=6; Error bars, except for the w/o 
groups, have been omitted for better visibility). B: Maximum Adsorption (Max). We defined Max as 
the values obtained between 57-60 min from the tracings in panel A (Fig. S1). Both surfactant 
proteins are important for reaching Max. Combined application of both ABs (n= 10-14) lead to a 
summative effect and significantly blocked Max adsorption. C: Rate of initial adsorption (Slope). 
Slope was calculated between 2-6 min from the tracings in panel A (Fig. S1). Both AB applications 
decreased the adsorption kinetics at initial stages; however there was no additive effect when applied 
in combination. Significant differences against w/o are indicated by asterisks (P*<0.05, P**<0.01, 
P***<0.001). Significant differences of combined application (aSPB+C) versus aSPB or aSPC are 
indicated with hashtags against SP-B (B#) and SP-C (C#), respectively (P#<0.05, P##<0.01, 
P###<0.001). RFU-bg: relative fluorescence units with subtracted background.  
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Fig. 6 
 
 
FIGURE6 Interfacial transfer of LBPs at the inverted interface experiments. A: Sketch of the 
microscopic setup. The thermostated chamber, filled with bath solution, is placed over a 40× LD 
objective. FM1-43 loaded LBPs were added on top. Thereupon adsorption dynamics was captured in 
a time lapse mode over 10 min. In protocol A the bath solution contained different AB 
concentrations. In protocol B, LBPs were pre-incubated with AB for 2h followed by a washout of 
unbound AB before addition to the chamber. B: Time resolved image series showing the arrival (0 to 
10 sec) and the subsequent adsorption (15 to 25 sec) of a single FM 1-43 loaded LBP at the inverted 
interface (Movie S4A and S4B). Image size 130x130 pixel. C: Left: Analysis of LBP adsorption. The 
representative tracings (n=4) show the cumulative count of LBPs arriving at the interface using 
protocol A or B. Right: Within the analyzed time (10 min), the number of sedimented LBPs was 
similar in both approaches (50±2 for w/o protocol A and 52±2 for w/o protocol B). AB treatment did 
not affect LBP sedimentation (n=20). Upper graph: protocol A, lower graph: protocol B. 
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Fig. 7 
 
FIGURE7 Blockage of LBPs adsorption. A: In protocol A, application of aSPB or aSPC in all 
concentrations showed a strong significant reduction of LBPs transformation. The combined 
application of aSPB and aSPC (aSPB+C) lead to a further specific reduction in comparison to 
individual AB application. B: In protocol B, application of aSPB lead to a significant inhibition of 
particle transformation at all concentrations. aSPC had significant effects at concentrations >10nM. 
Significant difference against w/o is indicated with asterisks P*<0.05, P**<0.01, P***<0.001 and 
against single application of aSPB or aSPC with hashtags P#<0.05, P##<0.01, P###<0.001 against 
aSPB and aSPC (n=10-15). 
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Fig. 8 
 
 
FIGURE8 LBPs velocity at the interface:  A: Time-lapse of adsorbing LBPs at the ALI over 30 min. 
At very early stages of the measurements, LBPs completely disintegrate (=disappear) upon ALI 
contact due to a high γ (=clean ALI). Subsequent LBPs adsorption is getting slower and incomplete, 
leaving behind smaller units amenable for analysis. Scale bar = 50 µm. Particles can be reliably 
recognized by using particle tracking plugin from MOSAIC plugin from ImageJ. The program 
detects spot-like surface structures of a defined cut-off for fluorescence intensity and pixel size B: 
Example of particle track over 10 min (Movie S5). Arrows indicate direction of particle. Scale bar = 
5 µm.  C: In control conditions particle velocity is highest at initial stages of adsorption due to high γ 
gradients. Curve describes decrease in particle velocity (µm/sec) as an exponential decay 
(Spearman’s corr. coeffi. =-0.93; P < 0.0001, n=4 representative tracks). D: Particle velocity within 
the first 10 min in protocol B. Blocking SP-B or SP-C individually leads to a significant reduction of 
particle velocity (i.e surface pressure) in almost all concentrations. Combined application of aSPB 
and aSPC (aSPB+C) lead to a further reduction. E: Particle velocity at initial events (protocol B). 
Using aSPB or aSPC in lower concentration (10nM-100nM) did not inhibit velocity. Combined 
application of 10nM aSPB+C showed a synergetic effect on surfactant surface activity.  Significant 
difference against w/o is indicated with asterisks P*<0.05, P**<0.01, P***<0.001 and combined 
33 
application versus single application of aSPB or aSPC is indicated with hashtags P#<0.05, P##<0.01, 
P###<0.001 against aSPB and aSPC (n=100-120). 
 
 
 
 
 
 
 
 
 
 
Fig. 9 
 
 
FIGURE9 Model for SP-B/C dependent adsorption of LPBs and its blocking by antibodies. A: 
ATP-driven pumping of surface active phospholipids by the ABCa3 protein of the LB limiting 
membrane is thought to generate the highly packed structure of lung surfactant stores in LBs. Upon 
secretion and associated to changes in the environment of LBs, a “closed state” of the SP-B-based 
machinery could be important to still maintain surfactant lipids in a highly packed state (=LBPs). 
When secreted LBPs contact with the ALI, a conformational change occurring at the SP-B/C 
machinery could trigger its opening to gain access to the internal lipid content and liberate a rapid 
flow and transfer of surface active species. B: In the presence of anti-SP-B and/or anti-SP-C 
antibodies, the machinery controlling the protein “gates” at the surface of LBPs could be 
permanently blocked, preventing the spreading of surfactant lipids at the interface. 
